01719nas a2200241   4500000000100000008004100001260001200042653001200054653002100066653002400087100001200111700001600123700001200139700001000151700001500161700001000176700001200186245010700198856006300305300001100368520108400379022001401463       2021                            d  c02/202110aCOVID1910aHansen's disease10acoronavirus disease1 aArora S1 aBhatnagar A1 aSingh G1 aPal R1 aBahuguna A1 aDas P1 aVerma P00aHansen's disease in the era of COVID-19: An observation on a series of six patients with co-infection.  uhttps://onlinelibrary.wiley.com/doi/epdf/10.1111/dth.14827  ae148273 a<p>Since the onset of the present pandemic, effect of the novel corona virus on other infectious conditions continues to be investigated. Although the immunological responses to SARS-Cov-2 infection have been elaborated extensively, they fail to explain, variations in its clinical manifestations and its interaction with other diseases. Hansen's disease is known to present as a complex immunological response to the lepra bacilli, resulting in its varied spectral manifestations. An interaction between these two infectious agents, hence, may affect Hansen's disease. We came across six cases of Hansen's disease who developed COVID19 co-infection. This series presents their clinical course and outcome, during the period of co-infection. All cases were followed up for a minimum eight-week period thereafter. In all these cases the active phase of coronavirus infection had no effect on Hansen's disease and those on prednisolone for their lepra reaction had a more favorable outcome, with two cases manifesting exacerbation of their lepra reactions in the follow period.</p>  a1529-8019